K5S-11311-93366
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 200 / DC
- Registered
- 2021-11-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-14
Dose 1 — Moderna
-
2021-05-12
Dose 2 — Moderna
-
2021-11-27
Registered in v-safe
-
2021-11-27
Dose 3 — Pfizer-BioNTech
- 2021-11-27
-
2021-11-30
Survey response — days 1–6 daily, dose 3MedDRA: Premature labour — Feeling: Good · Site: Pain · HeadacheFree text: I went into early labor 6 hours after receiving my 2nd shot. I wanted to report this through the team following outcomes in pregnancy.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Moderna | No |
| 2 | 2021-05-12 | Moderna | No |
| 3 | 2021-11-27 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I went into early labor 6 hours after receiving my 2nd shot. I wanted to report this through the team following outcomes in pregnancy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Premature labour | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release